Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Jan;16(1):e12669.
doi: 10.5812/ircmj.12669. Epub 2014 Jan 5.

Correlation of Body Mass Index and Serum Parameters With Ultrasonographic Grade of Fatty Change in Non-alcoholic Fatty Liver Disease

Affiliations

Correlation of Body Mass Index and Serum Parameters With Ultrasonographic Grade of Fatty Change in Non-alcoholic Fatty Liver Disease

Ghobad Abangah et al. Iran Red Crescent Med J. 2014 Jan.

Abstract

Background: Non-alcoholic fatty liver disease (NAFLD) is a common liver disease in the western population and expanding disease in the world. Pathological changes in fatty liver are like alcohol liver damage, which can lead to end-stage liver disease. The prevalence of NAFLD in obese or overweight people is higher than general population, and it seems that people with high Body Mass Index (BMI) or abnormality in some laboratory tests are more susceptible for severe fatty liver and high grade of NAFLD in ultrasonography (U.S).

Objectives: This study aimed to evaluate the correlation of BMI and laboratory tests with NAFLD in ultrasonography.

Materials and methods: During a multi-step process, we selected two-hundred and thirteen cases from four hundred and eighteen patients with NAFLD. Laboratory tests performed included: ALT, AST, FBS, Triglyceride and cholesterol levels, hepatitis B surface antigen, hepatitis C antibody, ceruloplasmin, serum iron, TIBC, transferrin saturation, ferritin, AMA, ANA, ANTI LKM1, serum protein electrophoresis, TSH, anti TTG (IgA). BMI and ultrasonography for 213 patients were performed, and then data was analyzed. These parameters and grades of ultrasonography were compared with the values obtained using one way ANOVA. An ordinal logistic regression model was used to estimate the probability of ultrasonography grade. The Statistical Package for the Social Science program (SPSS, version 16.0) was used for data analysis.

Results: Two-hundred and thirteen cases including 140 male and 73 female, were studied. In general, 72.3% of patients were overweight and obese. Post-hoc tests showed that only BMI (P < 0.001) and TG (P < 0.011) among variables had statistically significant associations with ultrasonography grade (USG), and ordinal logistic regression model showed that BMI and AST were the best predictors.

Discussion: Our results suggest that in patients with NAFLD, BMI and TG are most effective factors in severity of fatty liver disease and ultrasonography grade (USG). On the other hand, BMI as a predictor can be helpful. But, AST has not been a reliable finding, because it changes in many conditions.

Keywords: Aspartate Aminotransferase; Body Mass Index; Non-alcoholic Fatty Liver Disease; Triglyceride; Ultrasonography.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.. Serum Alanine Aminotransferase (ALT) and Aspartate Aminotransferase (AST) Levels in Different Ultrasonographic Groups. P values are for the Analysis of Variance (Post-hoc Comparisons) Considering the Mild Ultrasonographic Group as the Reference Category
Figure 2.
Figure 2.. Raw Data Plots of Single Selected Variables vs. Grade of Liver Disease. (A) Age vs. Grade. (B) Body Mass Index (BMI) vs. Grade. (C) Fasting Blood Sugar (FBS) vs. Grade. (D) Triglycerides (TG) vs. Grade

Similar articles

Cited by

References

    1. Lazo M, Clark JM. The epidemiology of nonalcoholic fatty liver disease: a global perspective. Semin Liver Dis. 2008;28(4):339–50. doi: 10.1055/s-0028-1091978. - DOI - PubMed
    1. Fan JG, Peng YD. Metabolic syndrome and non-alcoholic fatty liver disease: Asian definitions and Asian studies. Hepatobiliary Pancreat Dis Int. 2007;6(6):572–8. - PubMed
    1. Preiss D, Sattar N. Non-alcoholic fatty liver disease: an overview of prevalence, diagnosis, pathogenesis and treatment considerations. Clin Sci (Lond). 2008;115(5):141–50. doi: 10.1042/CS20070402. - DOI - PubMed
    1. Choudhury J, Sanyal AJ. Clinical aspects of fatty liver disease. Semin Liver Dis. 2004;24(4):349–62. doi: 10.1055/s-2004-860864. - DOI - PubMed
    1. Angulo P. Nonalcoholic fatty liver disease. N Engl J Med. 2002;346(16):1221–31. doi: 10.1056/NEJMra011775. - DOI - PubMed

LinkOut - more resources